| ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1 | |
| Jiao, Xiaodong; Yu, Wenlong; Qian, Jianxin; Chen, Ying; Wei, Peilian; Fang, Wenzheng; Yu, Guanzhen | |
| 刊名 | BMC CANCER
 |
| 2018 | |
| 卷号 | 18 |
| 关键词 | Hilar cholangiocarcinoma FoxM1 ADAMs ADAM-17 Prognosis |
| ISSN号 | 1471-2407 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3634962 |
| 专题 | 上海中医药大学 |
| 推荐引用方式 GB/T 7714 | Jiao, Xiaodong,Yu, Wenlong,Qian, Jianxin,et al. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1[J]. BMC CANCER,2018,18. |
| APA | Jiao, Xiaodong.,Yu, Wenlong.,Qian, Jianxin.,Chen, Ying.,Wei, Peilian.,...&Yu, Guanzhen.(2018).ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.BMC CANCER,18. |
| MLA | Jiao, Xiaodong,et al."ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1".BMC CANCER 18(2018). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论